{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:42:12Z","timestamp":1792694532820,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015507","name":"Shandong First Medical University","doi-asserted-by":"publisher","award":["202201-065"],"award-info":[{"award-number":["202201-065"]}],"id":[{"id":"10.13039\/501100015507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020MH031"],"award-info":[{"award-number":["ZR2020MH031"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejphar.2025.178429","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:13:35Z","timestamp":1764720815000},"page":"178429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A GLP-1 receptor agonist semaglutide attenuates cardiac microvascular injury in HFD\/STZ-induced diabetic mice"],"prefix":"10.1016","volume":"1011","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5314-4599","authenticated-orcid":false,"given":"Xinye","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178429_bib1","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1210\/en.2018-00004","article-title":"GLP-1 receptor expression within the human heart","volume":"159","author":"Baggio","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2025.178429_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13807","article-title":"Liraglutide treatment attenuates inflammation markers in the cardiac, cerebral and renal microvasculature in streptozotocin-induced diabetic rats","volume":"52","author":"Baylan","year":"2022","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2025.178429_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41401-022-00923-5","article-title":"EPSTI1 promotes monocyte adhesion to endothelial cells in vitro via upregulating VCAM-1 and ICAM-1 expression","volume":"44","author":"Bei","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2025.178429_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/nu16132087","article-title":"High-Fat diet augments myocardial inflammation and cardiac dysfunction in arrhythmogenic cardiomyopathy","volume":"16","author":"Centner","year":"2024","journal-title":"Nutrients"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2025.178429_bib5","article-title":"6. Cardio-renal protection in type 2 diabetes","volume":"222","author":"Colagiuri","year":"2025","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ejphar.2025.178429_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2016.06.009","article-title":"The cardiovascular biology of glucagon-like Peptide-1","volume":"24","author":"Drucker","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2025.178429_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176440","article-title":"Semaglutide alleviates gut microbiota dysbiosis induced by a high-fat diet","volume":"969","author":"Duan","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178429_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cbi.2015.11.032","article-title":"Challenges and issues with streptozotocin-induced diabetes - a clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics","volume":"244","author":"Goyal","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2025.178429_bib9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s42255-020-00327-x","article-title":"Metabolic Messengers: glucagon-like peptide 1","volume":"3","author":"Gribble","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ejphar.2025.178429_bib10","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.2147\/DDDT.S326975","article-title":"Maackiain protects the kidneys of type 2 diabetic rats via modulating the Nrf2\/HO-1 and TLR4\/NF-\u03baB\/Caspase-3 pathways","volume":"15","author":"Guo","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2025.178429_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031854","article-title":"Impact of glucagon-like peptide 1 receptor agonists on biochemical markers of the initiation of atherosclerotic process","volume":"25","author":"Hachu\u0142a","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178429_bib12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11274-024-04010-1","article-title":"Impact of Probiotic Lactiplantibacillus plantarum ATCC 14917 on atherosclerotic plaque and its mechanism","volume":"40","author":"Hassan","year":"2024","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejphar.2025.178429_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118163","article-title":"Unraveling the safety profile of GLP-1 receptor agonists: mechanistic insights with a focus on semaglutide","volume":"300","author":"He","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.178429_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/endrev\/bnaa025","article-title":"Microvascular dysfunction in diabetes mellitus and cardiometabolic disease","volume":"42","author":"Horton","year":"2021","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejphar.2025.178429_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166770","article-title":"Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice","volume":"1869","author":"Iwai","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2025.178429_bib16","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1161\/CIR.0000000000001040","article-title":"Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American heart Association","volume":"145","author":"Joseph","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.178429_bib17","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.cmet.2025.07.004","article-title":"Unexpected effects of semaglutide on skeletal muscle mass and force-generating capacity in mice","volume":"37","author":"Karasawa","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2025.178429_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/jdr\/7578626","article-title":"Mechanistic insights into Qidan Yixin Decoction for diabetic cardiomyopathy via macrophage polarization","volume":"2025","author":"Liu","year":"2025","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ejphar.2025.178429_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154710","article-title":"AGEs exacerbates coronary microvascular dysfunction in NoCAD by activating endoplasmic reticulum stress-mediated PERK signaling pathway","volume":"117","author":"Liu","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2025.178429_bib20","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1038\/s41467-024-48970-2","article-title":"Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5\/NR4a1 axis","volume":"15","author":"Ma","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.178429_bib21","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178429_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yjmcc.2024.05.004","article-title":"Expanding landscape of coronary microvascular disease in co-morbid conditions: metabolic disease and beyond","volume":"192","author":"McCallinhart","year":"2024","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2025.178429_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153732","article-title":"Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide","volume":"6","author":"McLean","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejphar.2025.178429_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13300-023-01493-3","article-title":"Comparison of effects of injectable semaglutide and dulaglutide on oxidative stress and glucose variability in patients with type 2 diabetes mellitus: a prospective preliminary Study","volume":"15","author":"Omachi","year":"2024","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.ejphar.2025.178429_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110196","article-title":"Semaglutide alleviates inflammation-induced endothelial progenitor cells injury by inhibiting MiR-155 expression in macrophage exosomes","volume":"119","author":"Pan","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2025.178429_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.213","article-title":"Protein disulfide isomerase-mediated apoptosis and proliferation of vascular smooth muscle cells induced by mechanical stress and advanced glycosylation end products result in diabetic mouse vein graft atherosclerosis","volume":"8","author":"Ping","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2025.178429_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051835","article-title":"The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation","volume":"21","author":"Poznyak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178429_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jacbts.2022.08.002","article-title":"Liraglutide lowers endothelial vascular cell adhesion Molecule-1 in murine atherosclerosis independent of glucose levels","volume":"8","author":"Punjabi","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.ejphar.2025.178429_bib29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jare.2025.01.003","article-title":"Ginseng-derived GABAFG ameliorates type 2 diabetes mellitus by modulating autophagy-lysosome pathway and gut microbiota","volume":"77","author":"Qi","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejphar.2025.178429_bib30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12951-024-02463-y","article-title":"Targeted delivery of MerTK protein via cell membrane engineered nanoparticle enhances efferocytosis and attenuates atherosclerosis in diabetic ApoE(-\/-) mice","volume":"22","author":"Qiu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejphar.2025.178429_bib31","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jacbts.2018.09.004","article-title":"The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE(-\/-) and LDLr(-\/-) mice by a mechanism that includes inflammatory pathways","volume":"3","author":"Rakipovski","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.ejphar.2025.178429_bib32","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.2147\/DDDT.S381546","article-title":"An effective glucagon-like Peptide-1 receptor agonists, semaglutide, improves sarcopenic obesity in Obese mice by modulating skeletal muscle metabolism","volume":"16","author":"Ren","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2025.178429_bib33","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2025.178429_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109647","article-title":"Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: involvement of the PI3K\/Akt\/GSK-3\u03b2 pathway","volume":"115","author":"Sadek","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2025.178429_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12933-024-02189-z","article-title":"Protective effects of imeglimin on the development of atherosclerosis in ApoE KO mice treated with STZ","volume":"23","author":"Sanada","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2025.178429_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137289","article-title":"RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism","volume":"5","author":"Senatus","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejphar.2025.178429_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/cph4.70003","article-title":"Type 2 diabetes mellitus: a comprehensive review of pathophysiology, comorbidities, and emerging therapies","volume":"15","author":"Singh","year":"2025","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.ejphar.2025.178429_bib38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tips.2021.11.001","article-title":"Physiological and pharmacological modulation of BAX","volume":"43","author":"Spitz","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2025.178429_bib39","doi-asserted-by":"crossref","first-page":"E989","DOI":"10.1152\/ajpendo.00465.2020","article-title":"Evaluation of glucagon-like peptide-1 receptor expression in nondiabetic and diabetic atherosclerotic mice using PET tracer (68)Ga-NODAGA-exendin-4","volume":"320","author":"St\u00e5hle","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2025.178429_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/ATVBAHA.124.321850","article-title":"Semaglutide improves myocardial perfusion and performance in a large animal model of coronary artery disease","volume":"45","author":"Stone","year":"2025","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2025.178429_bib41","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/dc19-1465","article-title":"Vasodilatory actions of glucagon-like peptide 1 are preserved in skeletal and cardiac muscle microvasculature but not in conduit artery in Obese humans with vascular insulin resistance","volume":"43","author":"Wang","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2025.178429_bib42","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s00125-024-06142-3","article-title":"Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial","volume":"67","author":"Wang","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2025.178429_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113517","article-title":"Glucose control independent mechanisms involved in the cardiovascular benefits of glucagon-like peptide-1 receptor agonists","volume":"153","author":"Wu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.178429_bib44","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2147\/DMSO.S425642","article-title":"GLP-1RA Liraglutide and semaglutide improves obesity-induced muscle atrophy via SIRT1 pathway","volume":"16","author":"Xiang","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.ejphar.2025.178429_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107748","article-title":"The diabetes drug semaglutide reduces infarct size, inflammation, and apoptosis, and normalizes neurogenesis in a rat model of stroke","volume":"158","author":"Yang","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2025.178429_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"Bmj"},{"key":"10.1016\/j.ejphar.2025.178429_bib47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12916-023-02887-7","article-title":"Adipsin alleviates cardiac microvascular injury in diabetic cardiomyopathy through Csk-dependent signaling mechanism","volume":"21","author":"Zhang","year":"2023","journal-title":"BMC Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:11:41Z","timestamp":1773879101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925011835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":47,"alternative-id":["S0014299925011835"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178429","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A GLP-1 receptor agonist semaglutide attenuates cardiac microvascular injury in HFD\/STZ-induced diabetic mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178429"}}